DSP Healthcare Fund
DSP Mutual Fund · Sectoral/Thematic · Regular plan, growth option
NAV (₹), 1 Oct 2026
44.4050
1-day change
-0.42%
1Y return
14.1%
3Y CAGR
19.1%
5Y CAGR
13.7%
Max drawdown, 5Y
−21.0%
NAV history month-end NAV, ₹ · 3 Dec 2018 to 1 Oct 2026
Returns vs Sectoral/Thematic median (259 schemes) and “Healthcare & pharma” median (19)
| Period | Scheme | Category median | Healthcare & pharma median |
|---|---|---|---|
| 1 month | -3.6% | -5.4% | -3.2% |
| 3 months | 2.9% | -3.1% | 2.7% |
| 6 months | 22.3% | 8.5% | 21.0% |
| Year to date | 13.3% | -2.6% | 16.3% |
| 1 year | 14.1% | 0.0% | 16.0% |
| 3 years (CAGR) | 19.1% | 11.7% | 19.2% |
| 5 years (CAGR) | 13.7% | 10.6% | 13.7% |
| 7 years (CAGR) | 24.1% | 15.7% | 23.7% |
| 10 years (CAGR) | n/a | 13.3% | 13.4% |
| Since first NAV (CAGR) | 20.9% | – | – |
“Healthcare & pharma” is MFIC's grouping of Sectoral/Thematic schemes by the theme or index in their names, not an AMFI category.
Rolling returns every business-day start date
| Measure | Scheme | Category median |
|---|---|---|
| 1Y rolling median | 19.1% | 9.8% |
| 3Y rolling median | 21.2% | 15.6% |
| 3Y rolling worst | 13.4% | 0.6% |
| 3Y periods positive | 100% | 100% |
| 3Y periods ahead of benchmark | 68% | 71% |
| 5Y rolling median | 23.6% | 14.2% |
| 5Y rolling worst | 12.7% | 0.3% |
| 5Y periods ahead of benchmark | 63% | 70% |
Benchmark: Nifty 500 (proxy: Motilal Oswal Nifty 500 Index Fund, price return).
Risk 36 months, monthly returns, Rf 6.5%
| Measure | Scheme | Category median |
|---|---|---|
| Standard deviation (ann.) | 15.1% | 16.7% |
| Sharpe ratio | 0.89 | 0.34 |
| Sortino ratio | 1.56 | 0.51 |
| Beta | 0.69 | 0.96 |
| Alpha (ann.) | 11.1% | 2.3% |
| Upside capture | 107.41 | 103.56 |
| Downside capture | 59.81 | 96.87 |
Drawdowns peak-to-trough falls in NAV
| Measure | Scheme | Category median |
|---|---|---|
| Maximum drawdown, full history | −22.1% | −23.7% |
| Maximum drawdown, last 10Y | n/a | −39.3% |
| Maximum drawdown, last 5Y | −21.0% | −22.8% |
| Current drawdown | −3.8% | −8.8% |
| Recovery time of worst fall | 389 days | – |
Longer histories include more crises, so compare the 5Y and 10Y figures across schemes of different ages.
Market context from Integrato Market Intelligence
This scheme invests mainly in the markets below, which are also close to how many of them are benchmarked. Where those markets stand today:
26,311.55 −0.48%
NSE close, 1 Oct 2026
- P/E 40.7: higher than 97% of days since 2019 (median 33.2)
- 1Y +21.5% · 3Y +19.9% p.a. · 5Y +13.1% p.a. (index fund NAV, after costs)
- −3.2% from its 52-week high
16,095.55 −0.26%
NSE close, 1 Oct 2026
- P/E 41.9: higher than 89% of days since 2020 (median 37.5)
- 1Y +12.4% · 3Y +18.3% p.a. · 5Y +12.2% p.a. (index fund NAV, after costs)
- −5.0% from its 52-week high (proxy NAV)
21,857.75 −0.97%
NSE close, 1 Oct 2026
- P/E 21.6: higher than 6% of days since 2019 (median 24.4)
- 1Y −3.9% · 3Y +8.9% p.a. · 5Y +8.6% p.a. (index fund NAV, after costs)
- −9.3% from its 52-week high
Index levels and P/E: NSE daily index closing values; gold and silver: IBJA rates; returns: growth NAV of an index fund or ETF tracking the market (AMFI), so they are after that fund's costs. Context only: a market's level or valuation does not tell you how any scheme will perform. Explore all markets.
Direct or Regular for this scheme?
The Regular plan's expense ratio is 2.05% a year and the Direct plan's 0.75%, a gap of 1.30%; over the last 3 years the Direct plan returned 1.60 percentage points a year more. On a ₹25,000 monthly SIP for 20 years (illustration at 12% a year before costs) the gap adds up to about ₹30,17,811.
With the Regular plan, that cost pays a distributor to help you plan, choose and review funds, and stay invested when markets fall. Whether it is worth it depends on how much of that you will do yourself.
TER: AMFI TER disclosure. Returns: AMFI NAVs. Illustration, not a guaranteed saving or return.
Fund managers and scheme facts Scheme Summary Document via AMFI
| Fund manager | Role | Managing since |
|---|---|---|
| Chirag Dagli | Primary (Equity and Overseas portion) | 1 Dec 2020 |
Objective: The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies/entities. There is no assurance that the investment objective of the Scheme will be achieved.
Stated asset allocation: 1.Equity and Equity related Instruments of Pharmaceutical and Healthcare companies / entities: 80% - 100% 2. Other Equity and Equity related Instruments/ Money Market Instruments / InvITs/ Gold ETFs / Silver ETFs / Other Liquid Instruments / Units of Domestic Mutual Funds^: 0% - 20% For detailed asset allocation pattern, please refer to the Scheme Information Document^Any other security as may be permitted by SEBI/ RBI from time to time. Other Liquid instruments includes cash, bank deposits with Scheduled Commercial Banks, Government Securities, Treasury bills, Repo on Government securities and any other instruments as specified by the SEBI. The scheme may invest in the units of Overnight F…
Benchmark (tier 1): BSE Healthcare TRI
Exit load: 0.50% - Holding period from the date of allotment <= 1 month, Nil - Holding period from the date of allotment > 1 month (as a % of Applicable NAV)
Minimum application: ₹100
Allotment date: 30 Nov 2018
Documents: Scheme Information Document · Scheme Summary Document. Read the scheme documents before investing.
Cost, size and riskometer as disclosed to AMFI
| Measure | Scheme | Category median |
|---|---|---|
| Expense ratio (TER), Regular plan | 2.05% | 2.38% |
| AUM, whole scheme (₹ crore) | 3,750 | 1,245 |
| Riskometer | Very High | – |
TER: AMFI, TER of MF Schemes. AUM and riskometer: AMFI, Fund Performance, 30 Sep 2026.
Official benchmark and category consistency
| Measure | Scheme | Benchmark / category |
|---|---|---|
| Return, 1 year (AMFI) | 15.8% | 16.8% TRI |
| Return, 3 years (AMFI) | 19.2% | 21.3% TRI |
| Return, 5 years (AMFI) | 13.8% | 14.6% TRI |
| Month-ends above category median (3Y CAGR) | 71% | 53% median |
| Month-ends in category top quartile (3Y) | 43% | 24% median |
Official benchmark: BSE Healthcare TRI (total return index, as published by AMFI). Category consistency: last 10 years of month-ends, Sectoral/Thematic Regular plans; how it is calculated.
Calendar-year returns NAV change from 31 Dec to 31 Dec
| Year | Scheme | Nifty 500 proxy | Difference |
|---|---|---|---|
| 2026 YTD | 13.3% | -7.8% | +21.0% |
| 2025 | -5.8% | 7.7% | −13.5% |
| 2024 | 40.7% | 15.6% | +25.0% |
| 2023 | 35.0% | 26.5% | +8.5% |
| 2022 | -7.8% | 3.8% | −11.6% |
| 2021 | 23.3% | 30.6% | −7.3% |
| 2020 | 76.9% | 17.2% | +59.7% |
| 2019 | 7.7% | n/a | – |
Benchmark proxy: Motilal Oswal Nifty 500 Index Fund (Direct plan NAV, price return), which carries its own costs. The first year starts from the first 31 December in the scheme's history.
Monthly SIP of ₹10,000 first business day of each month, ending 1 Oct 2026
| Period | Invested | Value | XIRR |
|---|---|---|---|
| 1 year | ₹1,20,000 | ₹1,33,244 | 21.1% |
| 3 years | ₹3,60,000 | ₹4,39,480 | 13.4% |
| 5 years | ₹6,00,000 | ₹9,24,681 | 17.3% |
Uses this plan's NAVs; ignores stamp duty, exit loads and taxes. One historical path only — the interactive SIP analyzer shows outcomes across every start date.
Scheme facts
AMC: DSP Mutual Fund
Category: Sectoral/Thematic
Plan / option: Regular · Growth
AMFI scheme code: 145456
ISIN: INF740KA1LD8
First NAV in MFIC data: 3 Dec 2018
History: 7.8 years
Portfolio holdings: see the scheme's monthly portfolio disclosure on the fund house website
Schemes that behaved similarly correlation of monthly returns, last 5 years
| Scheme | Category | Correlation | 3Y CAGR |
|---|---|---|---|
| UTI - Healthcare Fund | Sectoral/Thematic | 0.95 | 21.4% |
| LIC MF Healthcare Fund | Sectoral/Thematic | 0.95 | 19.4% |
| ITI Pharma and Healthcare Fund | Sectoral/Thematic | 0.95 | 16.7% |
| HDFC Pharma and Healthcare Fund | Sectoral/Thematic | 0.94 | 28.6% |
| ICICI Prudential Healthcare Fund | Sectoral/Thematic | 0.93 | 20.1% |
| Tata India Pharma & Healthcare Fund | Sectoral/Thematic | 0.93 | 16.5% |
Questions about DSP Healthcare Fund
- What is the latest NAV of DSP Healthcare Fund?
- The NAV of the Regular plan (growth option) was ₹44.4050 on 1 Oct 2026, as published by AMFI.
- Which category is DSP Healthcare Fund in?
- It is classified as Sectoral/Thematic in AMFI's daily NAV file; a Sectoral/Thematic scheme invests at least 80% in one sector or theme. MFIC compares it with 259 Sectoral/Thematic schemes (Regular plans).
- What returns has DSP Healthcare Fund delivered?
- Over one year the NAV changed by 14.1%. The 3-year CAGR is 19.1% (category median 11.7%) and the 5-year CAGR is 13.7% (category median 10.6%). Returns are after expenses and before tax. Past performance may or may not be sustained in future.
- How consistent have its 3-year returns been?
- Measuring a 3-year CAGR from every business day in its history, the median was 21.2%, the lowest was 13.4%, and 100% of 3-year periods ended with a gain. It was ahead of Nifty 500 (index-fund proxy) in 68% of those periods.
- What was the largest fall in DSP Healthcare Fund's NAV?
- The largest peak-to-trough fall in its available history was 22.1%; within the last five years it was 21.0% (category median 22.8%).
- How volatile is DSP Healthcare Fund?
- Its annualised standard deviation of monthly returns over the last 36 months is 15.1%, which is below the Sectoral/Thematic category median of 16.7%.
- What would a monthly SIP in DSP Healthcare Fund have grown to?
- A SIP of ₹10,000 on the first business day of each month for the last 5 years (60 instalments, ₹6,00,000 invested) would have been worth about ₹9,24,681 on 1 Oct 2026, an annualised return (XIRR) of 17.3%. This uses the Regular plan's NAVs, ignores taxes and exit loads, and past performance may or may not be sustained in future.
- What is the expense ratio (TER) of DSP Healthcare Fund?
- The total expense ratio of the Regular plan is 2.05% a year, as disclosed to AMFI (median of Sectoral/Thematic Regular plans: 2.38%). It is already deducted from the NAV, so every return shown is after expenses.
- How large is DSP Healthcare Fund?
- Assets under management of the whole scheme were ₹3,750 crore on 30 Sep 2026, as published by AMFI.
- What is the riskometer level of DSP Healthcare Fund?
- AMFI lists the scheme's riskometer as “Very High”, and its benchmark's as “Very High”. The riskometer is a label of potential risk set under SEBI rules, not a forecast.
- What is the benchmark of DSP Healthcare Fund and how has it compared?
- Its official benchmark is the BSE Healthcare TRI. Over 3 years AMFI reports a return of 19.2% for this plan against 21.3% for the benchmark total return index; over 5 years 13.8% against 14.6%. Past performance does not indicate future results.
- How often has DSP Healthcare Fund beaten its category?
- At 71% of the 58 month-ends compared over the last 10 years, its 3-year return was above the median of Sectoral/Thematic schemes (Regular plans); it was in the top quarter at 43% of them. A typical scheme would show about 50%.
- Who manages DSP Healthcare Fund?
- According to its Scheme Summary Document, DSP Healthcare Fund is managed by Chirag Dagli (since 1 Dec 2020).
- What is the exit load of DSP Healthcare Fund?
- As stated in its scheme documents: 0.50% - Holding period from the date of allotment <= 1 month, Nil - Holding period from the date of allotment > 1 month (as a % of Applicable NAV) Check the latest Scheme Information Document before investing, as loads can change.
- What is the minimum investment in DSP Healthcare Fund?
- The minimum application amount is ₹100. SIP details: SIP, SWP, STP - Rs. 100/- for all frequencies.
- What is the difference between the Direct and Regular plans?
- Both plans hold the same portfolio; the Regular plan includes distribution costs in its expense ratio. Over one year the Direct plan's NAV changed by 15.6% and the Regular plan's by 14.1%. The Regular plan includes the services of a distributor.
Reviewing your own mutual fund portfolio?
Integrato's team can walk you through how your current schemes have behaved, using the same data shown here. Integrato is an AMFI-registered Mutual Fund Distributor.
Follow DSP Healthcare Fund by email
Every Monday: this scheme's NAV, 1-month and 1-year return beside its category median, 3-year CAGR and how far it is below its peak. Add more schemes from their pages or from your MFIC watchlist. Free; unsubscribe from any email.
Data & disclosure. Source: AMFI daily NAV file and historical NAVs via mfapi.in; calculations by MFIC, as of 1 Oct 2026. Category medians use Regular plans in the same AMFI category. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance may or may not be sustained in future. This page is for research and education only and is not investment advice or a recommendation to buy, sell or hold any scheme. Integrato Financial Services Pvt. Ltd. is an AMFI-registered Mutual Fund Distributor (ARN-173155). Methodology.